Introduction
Obesity is an energy homeostasis disorder due to chronic imbalance between energy intake and expenditure (Hill et al., 2012) . The global epidemic of obesity is a major cause of the dramatically increased incidence of metabolic diseases such as diabetes, hyperlipidemia, and cancer (Rosen and Spiegelman, 2006) . Studies have established the white adipose tissue (WAT) as a dynamic organ that carries out several important energy homeostasis controlling physiological processes (Rosen and MacDougald, 2006) . Dissecting the molecular mechanisms that regulate the formation of adipocyte (adipogenesis) is thus critical.
Many factors cooperate elaborately to control adipogenesis (Sarjeant and Stephens, 2012) . Among them, peroxisome proliferator-activated receptor γ (PPARγ) is a key regulator that positively control the differentiation of preadipocytes into adipocytes (Tontonoz et al., 1994) , and the Wnt/β-catenin signaling is one of the key negative regulators of adipogenesis (Ross et al., 2000) . Canonical Wnt/β-catenin signaling can be activated either by Wnt ligands such as Wnt10b, Wnt10a, and Wnt6, or by chemicals that stabilize free cytosolic β-catenin (Ross et al., 2000; Wang et al., 2010) . The activated Wnt/β-catenin signaling results in β-catenin nucleus translocation, where it acts as a transcriptional coactivator to promote the expression of Wnt target genes, which further repress adipogenic commitment and adipogenesis (Singh et al., 2006; Wang et al., 2010; Yi et al., 2016) . However, literature reports on the non-canonical Wnt pathway initiated by Wnt5a in adipogenesis seem controversial. Wnt5a is reported to inhibit adipogenesis and promotes osteogenesis in human multipotent mesenchymal stem cells and human adipose tissue-derived mesenchymal stromal cells (Bilkovski et al., 2010) ; whereas in mouse preadipocytes, Wnt5a is reported to promote adipogenesis (Nishizuka et al., 2008) and upregulate PPARγ expression (van Tienen et al., 2009) .
Besides transcriptional factors, several epigenetic enzymes that regulate histone methylation or acetylation have been reported to regulate adipogenesis (Fu et al., 2005; Lee et al., 2008; Wang et al., 2013; Zha et al., 2015) . Despite their wellknown roles as key players in regulating chromatin structure and dynamics (Henikoff and Ahmad, 2005; Bonisch et al., 2012) , and as a key epigenetic code (Brunelle et al., 2015) , the function of histone variants in adipogenesis is unclear.
MacroH2A1 (mH2A1) and macroH2A2 (mH2A2), respectively encoded by H2AFY and H2AFY2, are two macroH2A (mH2A) variants of histone H2A family (Pehrson and Fried, 1992; Costanzi and Pehrson, 2001) . Alternative splicing of H2AFY results in macroH2A1.1 (mH2A1.1) and macroH2A1.2 (mH2A1.2), two isoforms that differ in only one exon in the macro-domain (Supplementary Figure S1A) . The macro-domain is known to interact with the NAD + -derived post-translational modifications such as mono-ADPribosylation and poly-ADP-ribosylation (PAR) (Karras et al., 2005) , which are catalyzed by a family of ADPribosyltransferases including the poly(ADP-ribose) polymerase 1 (PARP-1). Interestingly, only the macro-domain of mH2A1.1, but not that of mH2A1.2, interacts with PAR and PARP-1 Chen et al., 2014a, b) . Structurally, Gly 224 and Gly 314 on the macro-domain of mH2A1.1 are surrounded by O-acetyl-ADP-ribose phosphates . Consistently, mH2A1.1 G224E and mH2A1.1 G314E mutations
show abolished binding affinity to PAR and PARP-1 (Chen et al., 2014a, b) . This structural difference between mH2A1.1 and mH2A1.2 is important, since mH2A1.1 regulates the proliferation and metastatic potential of many cancer cells depending on its binding to NAD + -derived metabolites (Novikov et al., 2011; Dardenne et al., 2012) . Recently, mH2A1.2 is reported to be involved in adipogenesis (Pazienza et al., 2016) , whereas the role of mH2A1.1, especially the role of the macro-domain of mH2A1.1, in adipogenesis remains unknown. In this study, we found dramatically increased mH2A1.1 during 3T3-L1 differentiation, and in the white adipose tissue of obese mice. Using shRNA knockdown and overexpression, we demonstrated that mH2A1.1 plays a critical role in 3T3-L1 differentiation. We further found that mH2A1.1 directly binds with EZH2, a histone H3K27 methyltransferase, and led to repressed Wnt genes during adipogenesis. An important role of the macrodomain of mH2A1.1 in adipogenesis was also identified. Together, our study reveals a novel function of mH2A1.1 in the regulation of adipogenesis and obesity.
Results
The level of mH2A1.1 is increased during adipogenesis in 3T3-L1 cells
To determine the physiological relevance of mH2A1.1 and mH2A1.2 in regulating adipogenesis, we measured the mRNA and protein levels of mH2A1.1 and mH2A1.2 during the differentiation of 3T3-L1 cells. The induction procedure for 3T3-L1 preadipocyte to differentiate into mature adipocyte is provided (Supplementary Figure S1B) . Successful differentiation was demonstrated by gradually elevated protein levels of PPARγ1/2, and mRNA levels of Pparg2 and αP2, after treating cells with induction medium ( Figure 1A and B). The protein levels of mH2A1.1 and mH2A1.2 were both gradually increased from Day 0 to Day 6, with a dramatically decreased mH2A1.2 level on Day 8, during adipogenesis ( Figure 1A) . However, no change on the transcription level of mH2A1.1 (H2afy-3) or mH2A1.2 (H2afy-1) was observed during adipogenesis ( Figure 1B) .
Loss-of-function experiments were next performed in 3T3-L1 cells. The mRNA level of H2afy-3 or H2afy-1 was knocked down for about 50% and 30%, respectively, in shmH2A1.1 and shmH2A1.2 cells, while both H2afy-3 (52% reduction) and H2afy1 (35% reduction) were successfully knocked down in shmH2A1 cells ( Figure 1C) . Significantly downregulated protein levels of mH2A1.1/mH2A1.2, mH2A1.1 only, or mH2A1.2 only were found in shmH2A1, shmH2A1.1, or shmH2A1.2 cells, respectively ( Figure 1D ). Knockdown of mH2A1 or mH2A1.1, but not mH2A1.2, dramatically inhibited adipogenesis in 3T3-L1 cells as demonstrated by Oil Red O staining on Day 8 after induction ( Figure 1E ). Consistently, 30% or 40% decrease in total lipid level was found in mH2A1 or mH2A1.1 knockdown 3T3-L1 cells, respectively; while no change on total lipid level was observed in mH2A1.2 knockdown 3T3-L1 cells on Day 8 after induction ( Figure 1F ). These results indicate that it is mH2A1.1, but not mH2A1.2, which regulates adipogenesis in vitro. Figure 2A and B), similarly elevated protein levels of mH2A1.1 ( Figure 2A ) and mRNA levels of H2afy-3 ( Figure 2B ) were found in 3T3-L1 cells transfected with different mH2A1.1 ectopic constructs. Consistent with a previous report Figure 2C ). Furthermore, compared to normal cells on Day 7 after induction, the cells overexpressing mH2A1.1 accumulated twice as much lipid, whereas no change in total lipid level were found in cells overexpressing mH2A1.2 or two mH2A1.1 mutants ( Figure 2D ). Together, these results indicate that the macrodomain of mH2A1.1 plays an important role in regulating adipogenesis in vitro.
MacroH2A1.1 promotes adipocyte differentiation by inhibiting Wnt/β-catenin signaling To investigate how mH2A1.1 regulates adipocyte differentiation in 3T3-L1 cells, we examined the mRNA levels of several key adipogenesis activators and inhibitors. Significantly increased levels of Wnt10b, Wnt10a, Wnt5a, and Wnt6, but not Pparg, αP2, or Gata2, were observed in shmH2A1 and shmH2A1.1 cells, but not in shmH2A1.2 cells ( Figure 3A and Supplementary Figure S2A) . Consistently, increased protein levels of Wnt10b and Wnt5a, as well as increased nuclear location of β-catenin, were found in shmH2A1 and shmH2A1.1 cells, but not in shmH2A1.2 cells ( Figure 3B and C and Supplementary Figure S2B ).
On the other hand, >50% reduction in Wnt10b and Wnt5a, but not Pparg, αP2, Gata2, Wnt6, or Wnt10a, was found in cells overexpressing mH2A1.1, but not in cells overexpressing mH2A1.2, mH2A1.1 G224E , or mH2A1.1 G314E ( Figure 3D and Supplementary Figure S2C) . Furthermore, the protein levels of Wnt10b, β-catenin and Wnt5a were decreased in mH2A1.1 overexpressing cells, but not in cells overexpressing mH2A1.2 or two mH2A1.1 mutants ( Figure 3E and Supplementary Figure S2D ). These results suggest that the macro-domain of mH2A1.1 plays an important role in regulating Wnt/β-catenin signaling.
Restoration of mH2A1.1 in mH2A1.1 knockdown cells rescues adipogenesis in 3T3-L1 cells Since knockdown of mH2A1.1 inhibited adipogenesis, we next tested whether restoration of mH2A1.1 rescues adipogenesis in mH2A1.1 knockdown cells. Successful overexpression of WT, mH2A1.1 G224E and mH2A1.1 G314E in stable mH2A1.1 knockdown 3T3-L1 cells was confirmed by western blots and quantitative realtime PCR (qPCR) ( Figure 4A and B). Oil Red O staining and total lipid measurement suggested that only mH2A1.1, but not mH2A1.1 G224E or mH2A1.1
G314E
, could rescue the impaired adipogenesis in stable mH2A1.1 knockdown cells ( Figure 4C , inhibited the elevation of Wnt10b and Wnt5a in mH2A1.1 knockdown cells, while had no effect on the Pparg, αP2 and Gata2 levels ( Figure 4E and Supplementary Figure S2E) . Consistently, restoration of mH2A1.1, but not mH2A1.1 G224E , inhibited the mH2A1.1 knockdown-induced elevation of Wnt10b, β-catenin and Wnt5a ( Figure 4F and Supplementary Figure S2F ). Interestingly, although mH2A1.1 G314E did not inhibit the mH2A1.1 knockdown-induced elevation of Wnt5a and β-catenin, the Wnt10b level was affected ( Figure 4F ).
MacroH2A1.1 regulates Wnt genes by EZH2
Previous studies suggest that mH2A is positively correlated with the level of H3K27 trimethylation (H3K27me3) in regulating cellular differentiation and vertebrate development (Creppe et al., 2012; Gaspar-Maia et al., 2013) . We thus wonder that as a mH2A variant, mH2A1.1, may also regulate adipogenesis through histone methylation. To test this possibility, we examined several histone methylation markers, including H3K27me2, H3K27me3, H3K4me1, H3K4me2, H3K9me2, H3K36me2, and H3K79me2, in 3T3-L1 cells. We found significantly decreased levels of H3K27me2 and H3K27me3 after knockdown of mH2A1 or mH2A1.1, but not after knockdown of mH2A1.2 ( Figure 5A and Supplementary Figure S3A ). Furthermore, the protein level of EZH2, a H3K27 methyltransferase, was downregulated after knockdown of mH2A1 or mH2A1.1, but not after knockdown of mH2A1.2 ( Figure 5A ); on the other hand, no change in the protein levels of SUZ12 and EHMT2 was identified (Supplementary Figure  S3B) . Moreover, the mRNA levels of Ezh1, Ezh2, and Ehmt2 were unchanged in these cells ( Figure 5B ). Consistently, overexpression of mH2A1.1, but not mH2A1.1
increased H3K27me2, H3K27me3 and EZH2 levels in 3T3-L1 cells ( Figure 5C ). Furthermore, only restoration of mH2A1.1, but not mH2A1.1 G224E or mH2A1.1 G314E , normalized the mH2A1.1 knockdown-induced reduction of H3K27me2, H3K27me3, and EZH2 levels in 3T3-L1 cells ( Figure 5D ). However, the mRNA levels of Ezh1, Ezh2, and Ehmt2 were unchanged in 3T3-L1 cells either overexpress mH2A1.1 or restoration of mH2A1.1 after knockdown ( Figure 5E and F). These data suggest that mH2A1.1 regulates EZH2 at its protein level. Since EZH2 has been reported to directly repress the transcription levels of Wnt genes by regulating H3K27me3 levels on their promoters (Wang et al., 2010) , we wonder whether mH2A1.1 similarly affects the transcription of Wnt10b and Wnt5a. We performed ChIP assays to examine the binding affinities of H3K27me3 or H3K27me2 at four regions on Wnt10b promoter ( Figure 6A ) and at five regions on the promoter of Wnt5a (Supplementary Figure S4A) . Knockdown of mH2A1 and mH2A1.1, but not mH2A1.2, led to decreased H3K27me3 and H3K27me2 binding affinities on three out of four promoter locations of Wnt10b ( Figure 6B and C) . Furthermore, overexpression of mH2A1.1, but not mH2A1.1 G224E , mH2A1.1 G314E or mH2A1.2, resulted in increased H3K27me3 or H3K27me2 binding affinities on three promoter regions of Wnt10b ( Figure 6D and E). Consistently, knockdown of mH2A1 and mH2A1.1, but not mH2A1.2, led to decreased H3K27me3 binding affinities on locations 2, 3 and 4 of the Wnt5a promoter (Supplementary Figure  S4B) . Moreover, overexpression of mH2A1.1, but not mH2A1.1 G224E , mH2A1.1 G314E or WT mH2A1.2, resulted in increased H3K27me3 binding affinities on these locations of the Wnt5a promoter (Supplementary Figure S4D) . Although knockdown of mH2A1 and mH2A1.1, but not mH2A1.2, led to decreased H3K27me2 binding affinities on locations 3 and 4 of Wnt5a promoter (Supplementary Figure S4C) ; overexpressing mH2A1.1, but not mH2A1.1 G224E or mH2A1.1 G314E or mH2A1.2, resulted in increased H3K27me2 binding affinities on locations 2, 3 and 4 of the Wnt5a promoter, which is similar to those of H3K27me3 (Supplementary Figure S4E) . Together, these results indicate that mH2A1.1 regulates the recruitments of H3K27me3 and H3K27me2 on the promoters of Wnt genes.
MacroH2A1.1 binds to EZH2
To determine whether mH2A1.1 directly interacts with EZH2, co-IP assay was first performed using flag antibody in the EZH2-flag transfected cells. Binding of EZH2 to mH2A1.1, but not to mH2A1.2, was observed ( Figure 7A ). co-IP assay was also performed using antibodies against myc, Flag or EZH2 in mH2A1.1-myc, mH2A1.1 G224E -myc, mH2A1.1 G314E -myc, or mH2A1.2-Flag transfected 3T3-L1 cells. As we expected, mH2A1.1 was coimmunoprecipitated with EZH2 ( Figure 7B and C). Interestingly, mH2A1.1 G224E dramatically attenuated the binding of mH2A1.1 to EZH2, while mH2A1.1 G314E completely eliminated such binding ( Figure 7B and C) . No binding between EZH2 and mH2A1.2 was observed ( Figure 7B and C) .
Knockdown or overexpression of EZH2 has no effect on the levels of mH2A1.1 and mH2A1.2 To determine whether EZH2 affects the levels of mH2A1.1 or mH2A1.2, EZH2 was knockdown by siRNA in 3T3-L1 cells, the mRNA level of Ezh2 decreased by nearly 50%, while the levels of H2afy-3 and H2afy-1 remain unchanged (Supplementary Figure S5A) . Although the levels of H3K27me2, H3K27me3 and EZH2 were significantly downregulated after knockdown of EZH2, the protein levels of mH2A1.1 and mH2A1.2 were similar to those of the controls (Supplementary Figure S5B) . Moreover, in 3T3-L1 cells overexpressing EZH2, the mRNA and protein levels of mH2A1.1 and mH2A1.2 were unchanged (Supplementary Figure S5C and D) . These results suggest that EZH2 has no feedback effect on mH2A1.1 or mH2A1.2.
EZH2 is required for mH2A1.1 in regulating adipogenesis
Since knockdown of mH2A1.1 resulted in downregulation of EZH2, we next tested whether ectopically overexpressing EZH2 could rescue the mH2A1.1 knockdown-induced impairment of 3T3-L1 adipogenesis. EZH2 was significantly overexpressed in the stable mH2A1.1 knockdown cells without affecting the levels of H2afy-1 and H2afy-3 ( Figure 8A ). The levels of EZH2, H3K27me2, H3K27me3 and mH2A1.1 were dramatically decreased after knockdown of mH2A1.1, whereas overexpression of EZH2 rescued most of the mH2A1.1 knockdown-induced changes except the level of mH2A1.1 ( Figure 8B) . Furthermore, overexpression of EZH2 inhibited the mH2A1.1 knockdown-induced elevation of Wnt10b, as well as the mH2A1.1 knockdown-induced upregulation of Wnt10b and β-catenin ( Figure 8C and D) . More importantly, the Oil Red O staining and total lipid measurement results demonstrated that overexpression of EZH2 rescued adipogenesis in mH2A1.1 knockdown 3T3-L1 cells ( Figure 8E and F) . Above findings suggest that mH2A1.1 and EZH2 play critical roles in adipogenesis, we rationally suspect their levels may alter in the WAT of obese mice. To test this idea, we fed mice with chow diet (CD) or high fat diet (HFD) for 28 weeks and then examined the levels of mH2A1.1, mH2A1.2 and EZH2 on the sections of eWAT from CD-fed and HFD-fed mice. The physiological parameters of these mice are provided (Supplementary  Table S1 ). Compared to CD-fed mice, the eWAT of HFD-fed mice showed significantly increased protein levels of mH2A1.1 and MacroH2a1.1 regulates adipogenesis j 7 EZH2, while the level of mH2A1.2 was unchanged ( Figure 8G) , which indicates mH2A1.1 and EZH2 may have important roles in adipogenesis in vivo.
Discussion
Obesity is a complex metabolic disorder characterized by excessive accumulation of white fat in body, which is generally recognized as a contributing factor to other serious health conditions, such as heart disease and diabetes (Bluher, 2009) . Understanding the molecular mechanisms underlying adipogenesis may lead to new therapeutic approaches against obesity. In the present study, we report a novel role of macroH2A1.1, a histone variant, which regulates adipogenesis through upregulation of EZH2 that leads to enrichment of repressive epigenetic markers H3K27me2 and H3K27me3 on the promoter of Wnt genes.
Since mH2A1.1 and mH2A1.2 are both encoded by H2afy through alternative splicing, it is technically difficult to generate only mH2A1.1 or mH2A1.2 knockout mice (Gamble and Kraus, 2010; Pehrson et al., 2014) . The literature reports from H2afy KO mice on metabolic defects are controversial. No obvious defects in appearances, sizes, fertility or deficiency in births were found in H2afy KO mice (Pehrson et al., 2014) . Mice without H2afy are lean with reduced lipid accumulation in the liver under HFD stress (Sheedfar et al., 2015) . However, increased lipid accumulation in the liver was found in half of homozygous H2afy KO females even under CD-fed condition (Boulard et al., 2010) . A recent study showed that mice overexpressing mH2A1.2 exhibit lower adipose mass on HFD stress, and mH2A1.2-overexpressed 3T3-L1 cells display decreased lipid content upon differentiation (Pazienza et al., 2016) ; while in the same study, mH2A1.1-overexpressed 3T3-L1 cells show increased lipid accumulation upon differentiation (Pazienza et al., 2016) . Consistently, our data also demonstrated that mH2A1.1 promoted adipogenesis, and overexpression of mH2A1.1 in 3T3-L1 cells enhanced lipid accumulation after differentiation ( Figure 2C) . Moreover, we found increased expression of mH2A1.1 in the adipose tissues of HFD-fed mice. In addition to its fast increase at early days of differentiation, which was similar to mH2A1.1, the level of mH2A1.2 was reduced by nearly 50% on Day 8 as compared with Day 0 (Figure 1A ), while remained at low level on Day 10 upon differentiation (data not shown). We speculate the dramatically downregulated mH2A1.2 on Day 8 may possibly due to some unknown mechanism(s), such as decreased protein stability of mH2A1.2 by increasing ubiquitation or selective autophagy, which awaits further investigation. We also hypothesized that the low mH2A1.2 level may be a key factor to maintain cells as mature adipocytes.
A previous study has demonstrated that mH2A1 and mH2A2 both cooperate with the ploycomb repressive complex2 (PRC2), which consists of EZH2, EED, and SUZ12, to regulate developmental genes in human pluripotent cells (Buschbeck et al., 2009) . In the present study, we found that it is mH2A1.1, but not mH2A1.2, that binds to EZH2 and leads to altered H3K27me2 and H3K27me3, during adipogenesis. EZH2 has been reported to regulate canonical Wnt ligands during adipogenic commitment and adipogenesis (Wang et al., 2010; Yi et al., 2016) . Consistently, we found here that mH2A1.1 also downregulates the canonical Wnt ligand Wnt10b, via reducing its transcriptional level through recruiting H3K27me2 and H3K27me3 to its promoters. Taken together, our data suggest that mH2A1.1 interacts with EZH2 to methylate H3K27, which represses the transcription of Wnt10b, and leads to adipogenesis ( Figure 8H) .
The relationship between mH2A1.1 and Wnt genes is barely reported. By using ChIP-seq, a previous study reported that in a testicular cancer cell line NT2, mH2A regulates multiple genes involved in the developmental and transcriptional regulation, including Wnt genes (Buschbeck et al., 2009) . Furthermore, mH2As including mH2A1 and mH2A2 are found to enrich on the promoter of Wnt1 in NT2 cells (Buschbeck et al., 2009) , indicating mH2As may involve in adipogenesis by regulating Wnt genes expression. mH2A is usually regarded as a gene repressor in most reports (Buschbeck et al., 2009; Gaspar-Maia et al., 2013) , we thus hypothesized that mH2A1.1 may be a specific repressor for Wnt genes, since it can regulate both canonical (Wnt10b) and non-canonical (Wnt5a) Wnt ligands in this study. Both canonical and non-canonical Wnt/β-catenin signaling have been reported to play important roles in adipocyte differentiation (Cristancho and Lazar, 2011; Sarjeant and Stephens, 2012) . Generally, researchers agree that activation of canonical Wnt/β-catenin signaling inhibits adipogenesis (Cristancho and Lazar, 2011; Sarjeant and Stephens, 2012) . However, there are controversial reports about non-canonical Wnt pathway in adipogenesis (Nishizuka et al., 2008; Bilkovski et al., 2010; Cristancho and Lazar, 2011) , treating the human mesenchymal stem cells with recombinant Wnt5a protein results in reduced expressions of PPARγ, SREBP-1c and adiponectin, as well as mature adipocyte formation (Bilkovski et al., 2010) . Whereas knocking down Wnt4 or Wnt5a in 3T3-L1 cells, blocks adipocyte differentiation, with Wnt4 shows better effects (Nishizuka et al., 2008) . However, in mice, Wnt5a can manipulate inflammation in adipose tissue and obesity-induced insulin resistance; it does not affect body fat mass, adipocyte size and levels of adipocyte markers, including PARPγ (Fuster et al., 2015) . Our findings that mH2A1.1 regulates the expression of both canonical and noncanonical Wnt genes raise the possibility that there may exist a responsive sequence for mH2A1.1 on the promoters of Wnt genes, which will be of great future interesting for investigation.
Our results also suggest an essential role that the macrodomain plays in mH2A1.1-mediated adipogenesis. The macrodomain, which regulates the interaction with PARP-1, is suggested to be the cause of the different functions between mH2A1.1 and mH2A1.2 (Chen et al., 2014a, b) . PARP-1 (also known as ARTD1) knockout mice showed significantly reduced adipocyte size when fed HFD, and adipose-derived stromal cells isolated from ARTD1 −/− mice showed impaired ability to form matured adipocytes (Erener et al., 2012) . Furthermore, evidences suggest activated PARP-1 after the initial phase of adipogenesis, and either depletion of PARP1 or inhibition of the PARP-1 activity strongly retards the differentiation of 3T3-L1 cells (Janssen and Hilz, 1989; Lehmann et al., 2015) . Recent studies suggest the binding with PARP-1 is critical for the proper function of mH2A1.1, losing the interaction between mH2A1.1 and PARP-1 contributes to the increased proliferation and metastatic potential of some cancer cells (Novikov et al., 2011; Dardenne et al., 2012) . Furthermore, we also found two loss-offunction mutations, mH2A1.1 G224E and mH2A1.1 G314E , impaired adipocyte differentiation ( Figure 2C ). Besides previously reported PARP-1 binding functions of these two mutations, here we reported for the first time the critical role of macro-domain in binding EZH2 ( Figure 7B and C).
In conclusion, our results strongly imply a novel role for mH2A1.1 in regulating adipogenesis. The protein level of EZH2 is regulated by mH2A1.1, moreover, mH2A1.1 macro-domain dependently binds with EZH2, which leads to increased H3K27me2 and H3K27me3, histone transcriptional repressive markers to the promoters of Wnt genes to enhance adipogenesis. Furthermore, in human visceral adipose tissue, the expression level of mH2A1.1 is significantly higher in obese patients (BMI > 30) than those of mildly overweight , indicating the potential roles of mH2A1.1 in the development of human obesity (Pazienza et al., 2016) . Since mice without mH2A1 were lean, without obvious defects in appearances, sizes, or fertility (Pehrson et al., 2014) ; therefore, inhibition of mH2A1.1 may bypass side effects and serve as a potential therapeutic target against obesity.
Materials and methods

Cell culture
3T3-L1 cells (Cell Bank, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences) were grown in DMEM media (Hyclone) supplemented with 10% newborn bovine serum (BS, Gibco) and 1% sodium pyruvate (Hyclone). 293T cells were cultured in DMEM media supplemented with 10% fetal bovine serum (FBS, Hyclone) and 1% sodium pyruvate.
Confluent 3T3-L1 cells (counted as Day -2) went through contact inhibition for 2 days, and were treated with induction medium which is supplemented with 0.5 mM 3-isobutylmethylxanthine (Sigma), 1 mM dexamethasone (Sigma), 10 μg/ ml insulin (Sigma) and 10% FBS (Hyclone) (counted as Day 0). Four days later (counted as Day 4), cells were further cultured with media supplemented with 10 μg/ml insulin and 10% FBS. After another 2 days (counted as Day 6), cells were cultured with media containing only 10% FBS. 3T3-L1 cells become mature adipocytes on Day 7 or 8 post induction (Supplementary Figure S1B) . All in vitro experiments were repeated for at least three times.
Plasmids, transfection, and establishment of knockdown cell lines pCI-mH2A1.1-myc was obtained from Addgene (Supplementary Figure S1C) . The pCI-mH2A1.1 G224E -myc and pCI-mH2A1.1 G314E -myc constructs were prepared with standard procedures (Supplementary Figure S1C) and confirmed by sequencing as we previously described (Huang et al., 2015) . The human mH2A1.2 (NM_138610.2) was amplified by PCR from a 293T cDNA library, then subcloned into the eukaryotic expression vector pIRES with a Flag tag via EcoRI/NotI restriction sites (pIRES-mH2A1.2-flag; Supplementary Figure S1C ). pCI-EZH2-Flag was a kind gift from Dr Min Wu (Wuhan University). Cells were transfected with plasmids using Lipofectamine LTX (Invitrogen). To knockdown mH2A1.1 or mH2A1.2, 3T3-L1 cells were transfected with pSuper-puro vector containing either scramble shRNA or shRNA targeting mH2A1, mH2A1.1 or mH2A1.2 (shmH2A1, 5′-GCAATGCAGCAAGAGACAA-3′, shmH2A1.1, 5′-GAC ATTGCCTCGATCGACA-3′, shmH2A1.2, 5′-CCATAATCAATCCTACC AA-3′). Stable knockdown cell lines were established by puromycin (3 μg/ml, Amresco) selection as we previously described (Liu et al., 2017; Wang et al., 2017) . To knockdown EZH2, 3T3-L1 cells were transfected with vectors containing either scramble siRNA or siRNA targeting EZH2 (siEZH2, 5′-CAATAAAGATGAAGCC AAA-3′).
Oil Red O staining and total lipid measurement
On Day 7 or 8 post induction, cells were fixed with 4% formaldehyde in PBS, and stained with 0.5% Oil Red O (Sigma) in propylene glycol. Excessive staining was removed by washing the cells with 70% ethyl alcohol. Stained cells were photographed under a microscope (Nikon Eclipse Ti-S) or scanner (Epson perfection V370 Photo). Cellular total lipids were extracted by isopropyl alcohol and detected at 490 nm (Mutlskan FC, Thermo Scientific). The OD value of each group was first normalized to the total protein concentration, and reported as fold change where the shScram or NC group was arbitrarily set as one.
Immunofluorescence staining
Immunofluorescence staining was performed as we previously reported (Chen et al., 2014a; Cai et al., 2015) . Briefly, cells were fixed with 4% formaldehyde and blocked with 2% BSA (Amresco). A primary antibody against β-catenin (1:2000 dilution, Abcam) was applied overnight. The cells were then incubated with an antimouse antibody conjugated with TRITC (tetramethylrhodaminisothiocyanate), followed by DAPI co-staining, and images were taken using an Olympus BX60 microscope.
Western blot analysis
Freshly isolated cultured cells were sonicated in ice-cold RIPA buffer (Beyotime) and protein concentrations were determined. Proteins were fractionated by SDS-PAGE, electroblotted onto PVDF membrane (Millipore) and probed with respective primary antibodies (Supplementary Table S2 ). The targeted protein bands were visualized by enhanced chemiluminescence (Pierce) and evaluated using Quantity One 1-D Analysis Software (Bio-Rad) as we previously described (Li et al., 2012) . The expression levels of target proteins were first quantitated relative to loading controls in the same sample, and then the relative protein expression levels in different groups were normalized to the respective control group, which was arbitrarily set as one. Three independent experiments were performed with 1-2 replicates each time.
RT-PCR and qPCR
RNA was extracted from cells using RNAiso Plus (Takara Biotechnology) as we previously described (Liu et al., 2014) . cDNA synthesis was performed using the M-MLV First Strand Kit (Invitrogen). Primer sequences of the target genes for RT-PCR and qPCR are provided in Supplementary Table S3. For RT-PCR, PCR products were separated by electrophoresis using 1.5% agarose gels, and images were photographed using a Molecular Imager Gel Doc XR (Bio-Rad) as we previously described (Chen et al., 2015) . Band density was quantified using Quantity One 1-D Analysis Software. The mRNA level of the targeted gene was quantitated first against the Rn18s level from the same sample, then normalized to that of Day 0, which was set as one.
qPCR assays were performed with Super Real PreMix Plus (SYBR Green, TIANGEN Biotech) using a Bio-Rad iQ5 Real Time PCR System as we previously described (Chen et al., 2017) . The formation of a single product for each primer set was confirmed by observing only one peak in the melting curve for each reaction. Actb was used as internal control. The relative difference was expressed as the fold change calculated by the 2 -ΔΔCT method (Schmittgen and Livak, 2008; Li et al., 2015) , in which the ΔΔCT between the control group and the experimental group equals to (CT of target gene -CT of Actb) the experimental group -(CT of target gene -CT of Actb) the control group .
Co-immunoprecipitation (Co-IP)
Cells were lysed with IP lysis buffer (Beyotime) and protein concentrations were determined. Cell lysate (500 μg) was immunoprecipitated with specific antibodies (Supplementary Table S2 ) or respective IgGs with Dynabeads TM ProteinG (Thermo Scientific) overnight at 4°C. After washing the beads (IP lysis buffer with 50 mM NaCl), the beads were boiled in loading buffer and subjected to immunoblotting.
Chromatin immunoprecipitation (ChIP)
3T3-L1 cells were crosslinked with 1% formaldehyde and the reaction was stopped by 125 mM glycine. After washed with cold PBS, cells were resuspended with digestion buffer (50 mM Tris-HCl, pH7.6, 1 mM CaCl 2 , 0.2% Triton X-100) plus 1 mM PMSF. Chromatin was fragmented using Micrococcal Nuclease (New England Biolabs) and 1% of the supernatant was used as input for quantitation as we previously reported (Chen et al., 2015) . 350 μg of the fragmented chromatin was immunoprecipitated with the H3K27me2 or H3K27me3 antibody, or respective IgGs. The immunoprecipitated DNA was then extracted. qPCR was used to determine the enrichment of immunoprecipitated DNA vs. inputs with gene-specific primers to the specified regions. Primer sequences of the target genes for ChIP assay are provided in Supplementary Table S3 .
Immunohistochemical staining on WAT C57BL/6 male mice were obtained from the Wuhan University Animal Laboratory and housed in ventilated microisolator cages with free access to water. Mice were fed with either chow diet (CD) or high fat diet (HFD; 60% kcal fat; Research Diets) for 28 weeks from age of 6 week (Supplementary Table S1 ). All animal experiments were performed according to the Guidelines of the China Animal Welfare Legislation, as approved by the Committee on Ethics in the Care and Use of Laboratory Animals of College of Life Sciences, Wuhan University. Epididymal white adipocyte tissue (eWAT) was collected, embedded, sectioned, deparaffinized and rehydrated as we previously reported (Wang et al., 2011) .
For immunohistochemical studies, sections were incubated overnight with either anti-mH2A1.2 antibody (1:100 dilution) or anti-EZH2 antibody (1:100 dilution). After extensive washing, sections were further incubated with a biotinylated anti-rabbit antibody (Vector Laboratories). Positive staining was visualized by DAB substrate reaction (Vector Laboratories) following the ABC kit protocol (Vector Laboratories), and co-stained with hematoxylin.
For immunofluorescence staining, sections were incubated with an anti-mH2A1.1 antibody (1:100 dilution) followed by an anti-rabbit antibody conjugated with TRITC.
Statistical analysis
All results were expressed as the mean ± standard deviation (SD). Data were analyzed using the nonparametric KruskalWallis test followed by the Mann-Whitney test. Differences were considered statistically significant at P < 0.05.
Supplementary material
Supplementary material is available at Journal of Molecular Cell Biology online.
